| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |